June 30, 2023 We are hiring a Research Assistant to join our Innovation/R&D teams at Aegis Life, developing nucleic acid-based vaccines and therapeutics at our state-of-the-art laboratories in San Diego. The ideal candidate(s) will have a bachelor’s or master’s degree in biological sciences, biochemistry, or a related scientific
Read more →New grant from the Bill & Melinda Gates Foundation supports the development of genetic therapies for infectious diseases. Aegis Life and Entos Pharmaceuticals will work collaboratively to utilize the Fusogenix PLV gene therapy delivery platform to develop novel DNA-encoded therapeutics. June 07, 2023 08:00 AM Eastern Daylight
Read more →
EDMONTON, Alberta & SAN DIEGO–(BUSINESS WIRE)–Entos Pharmaceuticals, a clinical-stage biotechnology company developing genetic medicines with its Fusogenix proteolipid vehicle (PLV) nucleic acid delivery platform, announced today the opening of its new 9,600 square foot research and development facility in the Torrey Pines
Read more →Did you think it was over? Just for a moment, maybe – as the vaccination numbers rose, or the mercury; when the lockdowns lifted; as the masks dropped? The validation of Covid-19 vaccines will go down in history as a turning point during this pandemic, but with
Read more →AEGIS LIFE, INC. CONTINUES JOURNEY TO END PANDEMIC WITH COVID-19 DNA VACCINES Published by: Aegis Life Watch recording of Propel(x) Presents: Path to a COVID-19 Vaccine The COVID-19 vaccine developed by Pfizer and BioNTech SE prevented more than 90% of infections in a late-stage study, according to preliminary results. Vaccine development
Read more →AEGIS LIFE, INC. APPOINTS HONG JIANG, PH.D. AS CHIEF OPERATING OFFICER Published by: Aegis Life SAN DIEGO – September 9, 2020 – Aegis Life, Inc., the leading developer of the next generation of DNA vaccines and therapies for the world’s most dangerous diseases, announced today that it has
Read more →AEGIS LIFE, INC. LAUNCHES TO FIGHT COVID-19 VIA DNA VACCINES AND THERAPEUTICS ENABLED BY PROPRIETARY FUSOGENIX DELIVERY TECHNOLOGY Published by: Aegis Life Phase 1 Clinical Trial of Aegis Life’s First SARS-CoV-2 DNA Vaccine Planned for Fall 2020 Company Spun Out of Entos Pharmaceuticals SAN DIEGO – September
Read more →